Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review

Date: June 13, 2017
Pages: 59
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E5D61858624EN
Leaflet:

Download PDF Leaflet

Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review
Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North and South America, and Asia-Pacific. Eurofins is headquartered in Luxembourg.

Eurofins Scientific SE Key Recent Developments

Feb 28,2017: Eurofins: Full Year 2016 Results
Dec 08,2016: Eurofins appoints president of Eurofins Scientific
Oct 20,2016: Over 10% organic growth in the first nine months of 2016
Sep 14,2016: Jennifer Ohayon joins Eurofins Bioanalytical Services as Scientific Director for Large Molecule Bioanalysis
Aug 02,2016: Eurofins: Growth momentum sustained as strong Q1 operating trends continued in Q2 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Eurofins Scientific SE - Key Facts
Eurofins Scientific SE - Key Employees
Eurofins Scientific SE - Key Employee Biographies
Eurofins Scientific SE - Major Products and Services
Eurofins Scientific SE - History
Eurofins Scientific SE - Company Statement
Eurofins Scientific SE - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Eurofins Scientific SE - Business Description
Eurofins Scientific SE - SWOT Analysis
SWOT Analysis - Overview
Eurofins Scientific SE - Strengths
Eurofins Scientific SE - Weaknesses
Eurofins Scientific SE - Opportunities
Eurofins Scientific SE - Threats
Eurofins Scientific SE - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Eurofins Scientific SE, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 28, 2017: Eurofins: Full Year 2016 Results
Dec 08, 2016: Eurofins appoints president of Eurofins Scientific
Oct 20, 2016: Over 10% organic growth in the first nine months of 2016
Sep 14, 2016: Jennifer Ohayon joins Eurofins Bioanalytical Services as Scientific Director for Large Molecule Bioanalysis
Aug 02, 2016: Eurofins: Growth momentum sustained as strong Q1 operating trends continued in Q2 2016
Jun 13, 2016: Panel-based molecular diagnostics for infectious diseases: Biomnis partners with American laboratory Diatherix
Jun 13, 2016: Eurofins Lancaster Laboratories announces major expansion plans to enhance its laboratory services footprint and create new jobs in Ireland
Apr 25, 2016: Eurofins achieves 48% revenue growth and over 10% organic growth in Q1 2016
Feb 29, 2016: Outstanding 2015 results above recently upgraded objectives on all metrics Full year revenues up 38%, EBITDA up 50% Organic growth over 9.5% in Q4, almost 7.5% for the full year
Jan 22, 2016: Biomnis launches a test to determine the toxicity risk of widely-used chemotherapy

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Eurofins Scientific SE, Key Facts
Eurofins Scientific SE, Key Employees
Eurofins Scientific SE, Key Employee Biographies
Eurofins Scientific SE, Major Products and Services
Eurofins Scientific SE, History
Eurofins Scientific SE, Subsidiaries
Eurofins Scientific SE, Key Competitors
Eurofins Scientific SE, Ratios based on current share price
Eurofins Scientific SE, Annual Ratios
Eurofins Scientific SE, Annual Ratios (Cont.1)
Eurofins Scientific SE, Annual Ratios (Cont.2)
Eurofins Scientific SE, Interim Ratios
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Eurofins Scientific SE, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Eurofins Scientific SE, Performance Chart (2012 - 2016)
Eurofins Scientific SE, Ratio Charts
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

SGS SA
R-Biopharm AG
Intertek Group plc
Bureau Veritas SA
Skip to top


Ask Your Question

Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: